Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Propofol Reduction in ERCP
NCT05274984Phase 1Unknown
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Jan 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lidocaine, sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Primary endpoint: Propofol Consumption. Status: unknown.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT05274984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274984.